Extension of Time to File SOU

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1581 (Rev 09/2005)

OMB No. 0651-0054 (Exp 12/31/2020)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1581 (Rev 09/2005)

OMB No. 0651-0054 (Exp 12/31/2020)

SOU Extension Request
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:

MARK: WYZAFRI (see, http://uspto.report/TM/88399914/mark.png)
SERIAL NUMBER: 88399914

The applicant, Glaxo Group Limited, having an address of
      980 Great West Road
      Brentford, Middlesex, TW89GS
      United Kingdom
      XXXX (authorized)
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 10/08/2019.

For International Class 005:
Current identification: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.


The applicant's current attorney information: Merilee J. Arevalo. Merilee J. Arevalo of GSK, is located at

      LBP, 5.5A
      5 MOORE DRIVE
      RESEARCH TRIANGLE PARK, North Carolina 27709-3398
      United States
The docket/reference number is 82774771.

The phone number is 919-315-8204.

The fax number is 919-315-3023.

The email address is trademarks@gsk.com

The applicants proposed attorney information: Merilee J. Arevalo. Other appointed attorneys are Christopher M. Hanes, Terence A. Dixon, Michele A. Farber. Merilee J. Arevalo of GSK, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at

      LBP, 5.5A
      5 MOORE DRIVE
      RESEARCH TRIANGLE PARK, North Carolina 27709-3398
      United States
The docket/reference number is 82774771.

The phone number is 919-315-8204.

The fax number is 919-315-3023.

The email address is trademarks@gsk.com

Merilee J. Arevalo submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current correspondence information: MERILEE J. AREVALO. MERILEE J. AREVALO of GSK, is located at

      LBP, 5.5A
      5 MOORE DRIVE
      RESEARCH TRIANGLE PARK, North Carolina 27709-3398
      United States
The docket/reference number is 82774771.

The phone number is 919-315-8204.

The fax number is 919-315-3023.

The email address is trademarks@gsk.com

The applicants proposed correspondence information: MERILEE J. AREVALO. MERILEE J. AREVALO of GSK, is located at

      LBP, 5.5A
      5 MOORE DRIVE
      RESEARCH TRIANGLE PARK, North Carolina 27709-3398
      United States
The docket/reference number is 82774771.

The phone number is 919-315-8204.

The fax number is 919-315-3023.

The email address is trademarks@gsk.com


A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Merilee J. Arevalo/      Date Signed: 02/07/2020
Signatory's Name: Merilee J. Arevalo
Signatory's Position: Trademark Counsel, GSK, NJ and PA bar member
Signatory's Phone: 919-315-8204

Mailing Address:
   GSK
   LBP, 5.5A
   5 MOORE DRIVE
   RESEARCH TRIANGLE PARK, North Carolina 27709-3398

RAM Sale Number: 88399914
RAM Accounting Date: 02/10/2020

Serial Number: 88399914
Internet Transmission Date: Mon Feb 10 09:37:36 EST 2020
TEAS Stamp: USPTO/ESU-XXX.XX.XX.X-202002100937363340
61-88399914-700ea6b7e7990dda111adf170b99
6cabad489f23dd662d69a913930c65b50d63782-
DA-37341955-20200207140824362450